Opko Health
Price & Volume
Stats
See more52W Range | $0.97-$1.60 |
Market Cap | $1B |
Shares Short | 32M |
Financials
See moreRevenue (12 Mos) | $581.1M |
Revenue Growth (YoY) | -17.2% |
Gross Profit (12 Mos) | $86.6M |
Diluted EPS | -$0.27 |
News
See moreYahoo Finance • 29 days ago
Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026
Yahoo Finance • 3 months ago
OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
Yahoo Finance • 3 months ago
OPKO Health GAAP EPS of -$0.07 in-line, revenue of $124.2M misses by $6.57M
Yahoo Finance • 3 months ago
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
About
CEO | Dr. Phillip Frost M.D., Ph.D. |
CFO | Mr. Adam E. Logal |
Address | 4400 Biscayne Boulevard, Miami, FL, United States, 33137 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 2,275 |